Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps

類似資料

• Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
  著者:: Torene, Rebecca, 等
  出版事項: (2017)
• OR10-006 - Canakinumab in patients with TRAPS
  著者:: Lachmann, HJ, 等
  出版事項: (2013)
• Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
  著者:: Gattorno, Marco, 等
  出版事項: (2017)
• Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
  著者:: Lachmann, H, 等
  出版事項: (2015)
• Subclinical TRAPS treated with canakinumab
  著者:: M. Amatruda, 等
  出版事項: (2021-08-01)